HISAMITSU PHARMACEUTICAL CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,710 JPY | -1.01% |
|
-0.40% | -13.94% |
| Apr. 11 | Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 | MT |
| Jan. 12 | Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise | MT |
| Sales 2024 | 142B 911M | Sales 2025 * | 153B 983M | Capitalization | 281B 1.81B |
|---|---|---|---|---|---|
| Net income 2024 | 13.97B 89.79M | Net income 2025 * | 16.3B 105M | EV / Sales 2024 | 2.07 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.84 x |
| P/E ratio 2024 |
21.3
x | P/E ratio 2025 * |
17.2
x | Employees | 2,769 |
| Yield 2024 |
2.19% | Yield 2025 * |
2.43% | Free-Float | 61.22% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.01% | ||
| 1 week | -0.40% | ||
| Current month | -6.62% | ||
| 1 month | -8.05% | ||
| 3 months | -11.90% | ||
| 6 months | -23.39% | ||
| Current year | -13.94% |
1 week
3 695.00
3 799.00
1 month
3 695.004 038.00
Current year
3 695.004 593.00
1 year
3 541.005 497.00
3 years
3 230.006 650.00
5 years
3 230.007 750.00
10 years
3 230.009 950.00
| Managers | Title | Age | Since |
|---|---|---|---|
Shinichiro Takao
DFI | Director of Finance/CFO | 69 | 78-03-31 |
| President | 51 | 99-03-31 | |
| Chairman | 87 | 66-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 87 | 66-01-31 | |
| President | 51 | 99-03-31 | |
Shinichiro Takao
DFI | Director of Finance/CFO | 69 | 78-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.51% | 15 M€ | +5.53% | ||
| 0.04% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 3,710 | -1.01% | 203,900 |
| 24-04-24 | 3,748 | -0.85% | 122,000 |
| 24-04-23 | 3,780 | +0.16% | 101,800 |
| 24-04-22 | 3,774 | +1.48% | 172,700 |
| 24-04-19 | 3,719 | -0.51% | 170,500 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
Sector
Pharmaceuticals
Calendar
2024-07-03
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,710
JPY
Average target price
3,950
JPY
Spread / Average Target
+6.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.94% | 1.83B | |
| +24.17% | 562B | |
| -6.33% | 358B | |
| +19.90% | 322B | |
| +7.95% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.26% | 149B | |
| -6.47% | 146B |
- Stock Market
- Equities
- 4530 Stock
